← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 10, 2020Last known activity
Aug 28, 2025
Timeline
2000s
- Jun 1, 2006
Neurimmune AG— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT07213583Lead sponsorPhase 2Aug 28, 2025
- NCT04360434Lead sponsorPhase 1Feb 10, 2020
Details
- Founded
- Zurich, CH Jun 1, 2006
- Last known activity
- Aug 28, 2025